tsn

Clinical trial finds herbal medicine Sailuotong effective for mild cognitive impairment

 522
2 comments
Staff at TrialSite | Quality Journalism
Oct. 19, 2023, 7:00 p.m.

Sailuotong (SLT), a novel herbal extract, holds promise as a treatment for mild cognitive impairment (MCI) among older people, according to new research from Western Sydney University's NICM Health Research Institute in Australia. The trial's results, published in the journal Alzheimer's and Dementia, found participants taking SLT showed improvements in aspects of memory and executive function compared to those taking the placebo.

MCI is characterized by cognitive decline, including memory and thinking difficulties. The condition is often considered a precursor to dementia, particularly Alzheimer’s disease. No approved pharmaceutical interventions for MCI currently exist, and Alzheimer’s disease treatments are not considered safe or effective. Approximately 17% of people over the age of 60 are living with MCI globally.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News